Regulatory Wins Collide With Slipping Estimates
The Federal Aviation Administration certified the Boeing 737-10 on Oct. 20, clearing the final regulatory hurdle for the largest variant of the MAX family. Yet the market reaction was starkly negative. Boeing shares fell from $221.56 to $188.35, a drop of nearly 15% since the last earnings report, despite the certification and a new Navy contract.
The bottom line is that investors are looking past the headlines. While the company secured approval for the 737-10 and the Navy selected Boeing for the F/A-XX fighter, analyst confidence has eroded. The consensus estimate for third-quarter earnings per share slipped from -$0.1111 to -$0.201 over the last 90 days. Nine analysts issued downward revisions, while zero issued upward revisions in the past month.
This divergence between regulatory success and stock performance sets the stage for the Oct. 27 earnings release. The market is asking a simple question: can these approvals turn into cash? The answer depends on free cash flow, production rates, and margin recovery.
By The Numbers: Cash Flow and Debt
The figure that matters most in the upcoming report is free cash flow. In July, management guided that third-quarter free cash flow would be in the positive “low hundreds of millions.” This projection holds despite a significant $700 million payment to the Department of Justice. The full-year outlook remains at $1 billion to $3 billion.
Investors will note the company’s heavy debt load. Boeing’s debt stood at $45.9 billion, carrying roughly $600 million in quarterly interest expense. This interest burden eats into operating profits and makes the free cash flow target critical. If the company cannot generate cash from operations, the debt service becomes a persistent drag on shareholder value.
Last quarter, revenue rose 8.0% to $24.56 billion, and deliveries climbed 14% to 171 planes. Core earnings per share were -$0.76, missing the consensus estimate of -$0.34. However, free cash flow turned positive at $631 million, up from -$200 million a year earlier. Backlog reached a record $715 billion. The trend is improving, but the magnitude of the losses remains a concern.
737 Production Ramp and Wing Constraints
The 737 MAX program is the engine of Boeing’s commercial recovery. The 737-10 represents more than 30% of the 737 MAX program’s current order book, according to Boeing. Customers have ordered 7,350 737 MAX airplanes to date, with nearly 2,500 delivered as of September 2026.
Boeing is increasing 737 production to 47 per month and preparing for 52 on the Everett North Line. The target is 500 737 deliveries in 2026. However, management has identified wings as an internal weak spot as production rates rise. The company needs a clear update on how it is managing this supply constraint.
The 737-10 flight test program logged nearly 1,000 flights and over 2,000 flight hours. It seats 185 to 210 passengers and has a range of up to 3,100 nautical miles. Technological advancements result in a 20% reduction in CO2 emissions and fuel use compared to previous generations.
Commercial Airplanes posted a negative 2.7% operating margin in the previous quarter. The 737 and 787 cash margins were “slightly above breakeven.” The upcoming report must show proof that higher volume is covering fixed costs. If margins do not improve, the production ramp will not translate into bottom-line profit.
Defense Losses and 787 Delays
The defense division needs a cleaner quarter. A $280 million charge related to the VC-25B program pushed the division to a $15 million operating loss in the previous quarter. The Navy’s selection of Boeing for the F/A-XX fighter is a long-term win, but it does not offset immediate operational losses.
On the commercial side, the 787 Dreamliner faces its own challenges. GE engine deliveries were expected to resume in the third quarter. However, seat certifications could keep deliveries “a little bit lumpy.” This inconsistency makes it difficult to predict exact delivery numbers for the quarter.
CEO Kelly Ortberg stated in July that he cannot claim victory yet. This comment reflects the reality that regulatory wins are necessary but not sufficient. The company needs steady cash flow and cleaner factory numbers to back up the certification win.
Backlog Conversion and 2027 Expectations
The 737-10 certification opens a path to a backlog of more than 1,500 orders. The 2027 consensus earnings per share estimate is $3.7573. This figure assumes that the certification path turns into profit. However, the estimate has already dropped from $4.1043 over the last 90 days.
The market is pricing in execution risk. Boeing has the orders, but it must deliver them efficiently. The debt load, margin pressures, and supply chain constraints all weigh on the stock. The Oct. 27 report will reveal whether the company can convert its backlog into cash.
The FAA certification is a milestone, but it is not the finish line. The next step is financial stability. Investors will look for evidence that the production ramp is sustainable and that margins are expanding. If the company misses on free cash flow or margins, the stock could face further pressure.
The bottom line is that Boeing is in a transition phase. It has the regulatory approvals, but it needs the financial results to match. The Oct. 27 report is the test. If the numbers are weak, the stock will reflect the reality that regulatory wins do not automatically equal profit. If the numbers are strong, the stock may find a floor. The market is waiting for proof.
Sources
- Is Boeing Cleared for Departure? Latest FAA Win Sets the Stage for Q3 Earnings Showdown on Oct. 27
- Boeing
- FAA certifies Boeing 737-10
Photo: Sixflashphoto (CC BY-SA 4.0)
